Patients with severe NAFLD exhibit elevated levels of a specific variant of the ATG7 gene (p. P426L variant), along with increased expression and abundance of ATG7 mRNA and protein. The gene discussed is ATG7; the disease is metabolic dysfunction-associated steatotic liver disease.